Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

NCT07433933 | Completed

• 1 other identifier: LACER_2406_COS
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia (AGA). The main question it aims to answer is: • Does a shampoo use help to reduce the visible signs of hair loss related to TE and AGA? Subjects will use the shampoo for 3 months and visit the clinic for the visits established by the protocol.

Conditions

Telogen Effluvium; Androgenetic Alopecia

Outcome Measures

Primary Outcomes (1)

• Change in hair lenght and thickness

  From baseline to the end of use at 3 months.

Secondary Outcomes (1)

• Change in hair lenght and thickness at 1 month

  Baseline and 1 month of use

Study Arms (1)

anti-hair loss shampoo

Other: anti-hair loss shampoo

Interventions

anti-hair loss shampoo OTHER

anti-hair loss shampoo use for 3 months

anti-hair loss shampoo

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Clinic database

You may qualify if:

• Sex: Both (50% women; 50% men).
• Age: 18-65 years.
• Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio.
• Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men.
• Telogen effluvium: Combing test.
• Subjects with all hair types (oily, combination, sensitive, etc.).
• Subjects with all scalp types (normal, sensitive, etc.).
• Agree to participate voluntarily in the study and provide written informed consent.
• Adequate level of understanding of the clinical study.
• Good health (physical and mental).
• Availability to attend visits to the research centres.
• No application of any product to the experimental area on the first day of the trial.

You may not qualify if:

• Individuals under 18 years of age.
• Pregnant or breastfeeding women.
• Injuries or infection in the test area.
• History of allergies to cosmetic products.
• Known allergies to product components.
• Sensitivity to any product component.
• Patients who have undergone recent surgery or treatments in the study area.
• Cancer patients.
• Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study.
• Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at least 6 months.
• Hair cutting or dyeing during the study.
• Health problems, to be assessed by the specialist, that may compromise adherence to the study protocol.

Sponsors & Collaborators

• Lacer S.A.: lead

Study Sites (1)

Centro Médico Complutense Grupo Virtus

Alcalá de Henares, Madrid, 28805, Spain

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

Hypotrichosis; Hair Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 19, 2026
• First Posted: February 25, 2026
• Study Start: May 12, 2025
• Primary Completion: October 16, 2025
• Study Completion: October 16, 2025
• Last Updated: February 27, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)